The dose of paclitaxel used in the new approach was 16-fold lower than that typically used in free paclitaxel, but with similar efficacy.

Researchers discovered peptides that permanently block a key cancer protein once thought untreatable, using a new screening ...

We recently published a list of Top 8 AI News Updates Driving Markets Today. In this article, we are going to take a look at ...

A recent study published in Engineering has shed new light on the mechanisms underlying the metastasis of head and neck ...

Title: ATNM-400 is a novel Actinium-225 antibody radioconjugate with strong efficacy in preclinical models of prostate cancer ...

Research into selective androgen receptor modulators (SARMs) continues to evolve in laboratory settings. Ostarine and ...

Lantern is a leader in the development of tech-bio to deliver the next generation of cancer medicines, where success is defined by both AI-driven progress and meaningful patient outcomes," said Panna ...

Since its development five years ago, the research method has identified more than 30 new rare diseasesThe Xenopus diagnostic ...

Becoming an embryo and attaching and forming a fetus is evidence that there is a new individual that is “on the path.” This ...

SHANGHAI, NANJING, China and SAN JOSE, Calif., March 28, 2025 /PRNewswire/ -- IASO Biotherapeutics ('IASO Bio'), a biopharmaceutical company focused on the discovery, development, manufacturing, and ...

A new anti-HER2 IgE antibody potentially offers new therapy options for treatment-resistant breast and ovarian cancers.